Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan · Delayed Price · Currency is TWD 18.50
-0.15 (-0.80%)
Apr 20, 2026, 10:25 AM CST
Welgene Biotech Market Cap
Welgene Biotech has a market cap or net worth of 434.62 million as of April 20, 2026. Its market cap has decreased by -20.64% in one year.
Market Cap
434.62M
Enterprise Value
398.10M
Revenue
375.94M
Ranking
n/a
PE Ratio
326.79
Stock Price
18.50
Market Cap Chart
Since October 23, 2017, Welgene Biotech's market cap has decreased from 575.10M to 434.62M, a decrease of -24.43%. That is a compound annual growth rate of -3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 431.13M | -0.54% |
| Dec 31, 2025 | 433.46M | -21.85% |
| Dec 30, 2024 | 554.64M | 6.49% |
| Dec 29, 2023 | 520.85M | 0.68% |
| Dec 30, 2022 | 517.35M | -9.20% |
| Dec 30, 2021 | 569.79M | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 61.63B |
| Heron Neutron Medical | 61.19B |
| Golden Biotechnology | 562.93M |
| Health & Life | 545.19M |
| Pharmigene | 514.74M |
| Taiwan Advanced Nanotech | 470.20M |